BDBM102144 US8530648, 41

SMILES: FC(F)(F)c1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1

InChI Key: InChIKey=PCRQKFMWHPQKKH-UHFFFAOYSA-N

Data: 2 KI  2 Kd

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 102144   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Orexin receptor type 2 (Homo sapiens (Human))	BDBM102144 (US8530648, 41) Show SMILES FC(F)(F)c1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H25F3N4O/c26-25(27,28)19-6-3-5-18(15-19)17-32-12-4-9-24(23(32)33)10-13-31(14-11-24)22-16-29-20-7-1-2-8-21(20)30-22/h1-3,5-8,15-16H,4,9-14,17H2	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	112	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Novartis AG US Patent					Assay Description FLIPR assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM102144 (US8530648, 41) Show SMILES FC(F)(F)c1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H25F3N4O/c26-25(27,28)19-6-3-5-18(15-19)17-32-12-4-9-24(23(32)33)10-13-31(14-11-24)22-16-29-20-7-1-2-8-21(20)30-22/h1-3,5-8,15-16H,4,9-14,17H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	948	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Novartis AG US Patent					Assay Description FLIPR assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM102144 (US8530648, 41) Show SMILES FC(F)(F)c1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H25F3N4O/c26-25(27,28)19-6-3-5-18(15-19)17-32-12-4-9-24(23(32)33)10-13-31(14-11-24)22-16-29-20-7-1-2-8-21(20)30-22/h1-3,5-8,15-16H,4,9-14,17H2	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	211	n/a	n/a	n/a	7.5	n/a
Novartis AG US Patent					Assay Description Radioligand binding assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM102144 (US8530648, 41) Show SMILES FC(F)(F)c1cccc(CN2CCCC3(CCN(CC3)c3cnc4ccccc4n3)C2=O)c1 Show InChI InChI=1S/C25H25F3N4O/c26-25(27,28)19-6-3-5-18(15-19)17-32-12-4-9-24(23(32)33)10-13-31(14-11-24)22-16-29-20-7-1-2-8-21(20)30-22/h1-3,5-8,15-16H,4,9-14,17H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	1.38E+3	n/a	n/a	n/a	7.5	n/a
Novartis AG US Patent					Assay Description Radioligand binding assay using orexin receptor.				US Patent US8530648 (2013) BindingDB Entry DOI: 10.7270/Q2SB44DR
					More data for this Ligand-Target Pair